EPO mediates neurotrophic, neuroprotective, anti-oxidant, and anti-apoptotic effects via downregulation of miR-451 and miR-885-5p in SH-SY5Y neuron-like cells

Frontiers in Immunology

Volumn 5, Issue SEP, 2014, Pages

  Alural, Begum ^a   Duran, Gizem Ayna ^a   Tufekci, Kemal Ugur ^a   Allmer, Jens ^b   Onkal, Zeynep ^a   Tunali, Doga ^a   Genc, Kursad ^a   Genc, Sermin ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b IZMIR INSTITUTE OF TECHNOLOGY   (Turkey)

Author keywords

Apoptosis; Cell death; Erythropoietin; Migration; MiRNAs; Neurite outgrowth; Oxidative stress; Proliferation

Indexed keywords

ANTIOXIDANT; CYCLIN DEPENDENT KINASE 2; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; GALANIN; MATRIX METALLO PEPTIDASE 9; MICRORNA; MINICHROMOSOME MAINTENANCE PROTEIN 5; MIR 451; MIR 885 5P; PEPTIDASE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANTI APOPTOTIC EFFECT; ANTI OXIDANT EFFECT; ARTICLE; BIOLOGICAL ACTIVITY; CELL DEATH; CELL MIGRATION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CELL VIABILITY; CONTROLLED STUDY; DNA FRAGMENTATION ASSAY; DOWN REGULATION; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; NERVE CELL; NERVE FIBER GROWTH; NEUROPROTECTION; NEUROTROPHIC EFFECT; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; UPREGULATION; WST-8 ASSAY;

EID: 84918542258     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00475     Document Type: Article

References (44)

1. Jelkmann W. Physiology and pharmacology of erythropoietin. Transfus Med Hemother (2013) 40(5):302-9. doi: 10.1159/000356193
2. Kumral A, Tüzün F, Oner MG, Genç S, Duman N, Ozkan H. Erythropoietin in neonatal brain protection: the past, the present and the future. Brain Dev (2011) 33(8):632-43. doi:10.1016/j.braindev.2010.10.014
3. Ogunshola OO, Bogdanova AY. Epo and non-hematopoietic cells: what do we know? Methods Mol Biol (2013) 982:13-41. doi:10.1007/978-1-62703-308-4_2
4. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A (2000) 97(19):10526-31. doi:10.1073/pnas.97.19.10526
5. Genc S, Koroglu TF, Genc K. Erythropoietin and the nervous system. Brain Res (2004) 1000(1-2):19-31. doi:10.1016/j.brainres.2003.12.037
6. Sargin D, Friedrichs H, El-Kordi A, Ehrenreich H. Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research. Best Pract Res Clin Anaesthesiol (2010) 24(4):573-94. doi:10.1016/j.bpa.2010.10.005
7. Maiese K, Chong ZZ, Shang YC, Wang S. Erythropoietin: new directions for the nervous system. Int J Mol Sci (2012) 13(9):11102-29. doi:10.3390/ijms130911102
8. Chong ZZ, Shang YC, Mu Y, Cui S, Yao Q, Maiese K. Targeting erythropoietin for chronic neurodegenerative diseases. Expert Opin Ther Targets (2013) 17(6):707-20. doi:10.1517/14728222.2013.780599
9. Renzi MJ, Farrell FX, Bittner A, Galindo JE, Morton M, Trinh H, et al. Erythropoietin induces changes in gene expression in PC-12 cells. Brain Res Mol Brain Res (2002) 104(1):86-95. doi:10.1016/S0169-328X(02)00323-6
10. Juul SE, McPherson RJ, Bammler TK, Wilkerson J, Beyer RP, Farin FM. Recombinant erythropoietin is neuroprotective in a novel mouse oxidative Injury model. Dev Neurosci (2008) 30(4):231-42. doi:10.1159/000110348
11. Juul SE, Beyer RP, Bammler TK, McPherson RJ, Wilkerson J, Farin FM. Microarray analysis of high-dose recombinant erythropoietin treatment of unilateral brain injury in neonatal mouse hippocampus. Pediatr Res (2009) 65(5):485-92. doi:10.1203/PDR.0b013e31819d90c8
12. Maurer MH, Frietsch T, Waschke KF, Kuschinsky W. Cerebral transcriptome analysis of transgenic mice overexpressing erythropoietin. Neurosci Lett (2002) 327(3):181-4. doi:10.1016/S0304-3940(02)00425-1
13. Mengozzi M, Cervellini I, Villa P, Erbayraktar Z, Gökmen N, Yilmaz O, et al. Erythropoietin-induced changes in brain gene expression reveal induction of synaptic plasticity genes in experimental stroke. Proc Natl Acad Sci U S A (2012) 109(24):9617-22. doi:10.1073/pnas.1200554109
14. Anderson GD, Peterson TC, VonderHaar C, Kantor ED, Farin FM, Bammler TK, et al. Comparison of the effects of erythropoietin and anakinra on functional recovery and gene expression in a traumatic brain injury model. Front Pharmacol (2013) 4:129. doi:10.3389/fphar.2013.00129
15. Tüfekci KU, Meuwissen RL, Genç S. The role of microRNAs in biological processes. Methods Mol Biol (2014) 1107:15-31. doi:10.1007/978-1-62703-748-8_2
16. Lee RC, Feinbaum RL, Ambros V. The C. elegansheterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell (1993) 75(5):843-54. doi:10.1016/0092-8674(93)90529-Y
17. Follert P, Cremer H, Béclin C. MicroRNAs in brain development and function: a matter of flexibility and stability. Front Mol Neurosci (2014) 7:5. doi:10.3389/fnmol.2014.00005
18. Kosaka N, Sugiura K, Yamamoto Y, Yoshioka Y, Miyazaki H, Komatsu N, et al. Identification of erythropoietin-induced microRNAs in haematopoietic cells during erythroid differentiation. Br J Haematol (2008) 142(2):293-300. doi:10.1111/j.1365-2141.2008.07151.x
19. Keller A, Leidinger P, Lange J, Borries A, Schroers H, Scheffler M, et al. Multiple sclerosis: microRNA expression profiles accurately Differentiate patients with relapsing-remitting disease from healthy controls. PLoS One (2009) 4(10):e7440. doi:10.1371/journal.pone.0007440
20. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrica (1988) 75:185-93. doi:10.1093/biomet/75.4.800
21. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B (1995) 57:289-300.
22. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc (2008) 3(6):1101-8. doi:10.1038/nprot.2008.73
23. Hsu SD, Lin FM, Wu WY, Liang C, Huang WC, Chan WL, et al. miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res (2011) 39:D163-9. doi:10.1093/nar/gkq1107
24. Vergoulis T, Vlachos IS, Alexiou P, Georgakilas G, Maragkakis M, Reczko M, et al. TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support. Nucleic Acids Res (2012) 40:D222-9. doi:10.1093/nar/gkr1161
25. D'Eustachio P. Reactome knowledgebase of human biological pathways and processes. Methods Mol Biol (2011) 694:49-61. doi:10.1007/978-1-60761-977-2_4
26. Brines M, Cerami A. The receptor that tames the innate immune response. Mol Med (2012) 18:486-96. doi:10.2119/molmed.2011.00414
27. Nairz M, Sonnweber T, Schroll A, Theurl I, Weiss G. The pleiotropic effects of erythropoietin in infection and inflammation. Microbes Infect (2012) 14(3):238-46. doi:10.1016/j.micinf.2011.10.005
28. Pregi N, Vittori D, Pérez G, Leirós CP, Nesse A. Effect of erythropoietin on staurosporine-induced apoptosis and differentiation of SH-SY5Y neuroblastoma cells. Biochim Biophys Acta (2006) 1763(2):238-46. doi:10.1016/j.bbamcr.2005.12.011
29. Um M, Gross AW, Lodish HF. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells. Cell Signal (2007) 19(3):634-45. doi:10.1016/j.cellsig.2006.08.014
30. Wenker SD, Chamorro ME, Vittori DC, Nesse AB. Protective action of erythropoietin on neuronal damage induced by activated microglia. FEBS J (2013) 280(7):1630-42. doi:10.1111/febs.12172
31. Qiu J, Zhou XY, Zhou XG, Cheng R, Liu HY, Li Y. Neuroprotective effects of microRNA-210 against oxygen-glucose deprivation through inhibition of apoptosis in PC12 cells. Mol Med Rep (2013) 7(6):1955-9. doi:10.3892/mmr.2013.1431
32. Zeng L, He X, Wang Y, Tang Y, Zheng C, Cai H, et al. MicroRNA-210 overexpression induces angiogenesis and neurogenesis in the normal adult mouse brain. Gene Ther (2014) 21(1):37-43. doi:10.1038/gt.2013.55
33. Lee K, Kim JH, Kwon OB, An K, Ryu J, Cho K, et al. An activity-regulated microRNA, miR-188, controls dendritic plasticity and synaptic transmission by downregulating neuropilin-2. J Neurosci (2012) 32(16):5678-87. doi:10.1523/JNEUROSCI.6471-11.2012
34. Yuen CM, Leu S, Lee FY, Yen CH, Lin YC, Chua S, et al. Erythropoietin markedly attenuates brain infarct size and improves neurological function in the rat. J Investig Med (2010) 58(7):893-904. doi:10.231/JIM.0b013e3181e80c40
35. Rosenstein JM, Krum JM, Ruhrberg C. VEGF in the nervous system. Organogenesis (2010) 6(2):107-14. doi:10.4161/org.6.2.11687
36. Hobson SA, Bacon A, Elliot-Hunt CR, Holmes FE, Kerr NC, Pope R, et al. Galanin acts as a trophic factor to the central and peripheral nervous systems. EXS (2010) 102:25-38. doi:10.1007/s00018-008-8154-7
37. Mengozzi M, Ermilov P, Annenkov A, Ghezzi P, Pearl F. Definition of a family of tissue-protective cytokines using functional cluster analysis: a proof-of-concept study. Front Immunol (2014) 5:115. doi:10.3389/fimmu.2014.00115
38. Hellewell SC, Yan EB, Alwis DS, Bye N, Morganti-Kossmann MC. Erythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor. J Neuroinflammation (2013) 10:156. doi:10.1186/1742-2094-10-156
39. Afanasyeva EA, Mestdagh P, Kumps C, Vandesompele J, Ehemann V, Theissen J, et al. MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and Inhibits proliferation and survival. Cell Death Differ (2011) 18(6):974-84. doi:10.1038/cdd.2010.164
40. Ferracin M, Bassi C, Pedriali M, Pagotto S, D'Abundo L, Zagatti B, et al. miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression. Mol Cancer (2013) 12(1):130. doi:10.1186/1476-4598-12-130
41. Stachurska A, Ciesla M, Kozakowska M, Wolffram S, Boesch-Saadatmandi C, Rimbach G, et al. Cross-talk between microRNAs, nuclear factor E2-related factor 2, and heme oxygenase-1 in ochratoxin A-induced toxic effects in renal proximal tubular epithelial cells. Mol Nutr Food Res (2013) 57(3):504-15. doi:10.1002/mnfr.201200456
42. Chamorro ME, Wenker SD, Vota DM, Vittori DC, Nesse AB. Signaling pathways of Cell proliferation are involved in the differential effect of erythropoietin and Its carbamylated derivative. Biochim Biophys Acta (2013) 1833(8):1960-8. doi:10.1016/j.bbamcr.2013.04.006
43. Hu G, Drescher KM, Chen XM. Exosomal miRNAs: biological properties and therapeutic potential. Front Genet (2012) 3:56. doi:10.3389/fgene.2012.00056
44. Patz S, Trattnig C, Grünbacher G, Ebner B, Gülly C, Novak A, et al. More than cell dust: microparticles isolated from cerebrospinal fluid of brain injured patients are messengers carrying mRNAs, miRNAs, and proteins. J Neurotrauma (2013) 30(14):1232-42. doi:10.1089/neu.2012.2596